Efficacy of thrombin spray combined with clip closure after colorectal endoscopic mucosal resection and endoscopic submucosal dissection

Table 8 Comparison of European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scores between two groups preoperatively and at 1 month postoperatively (points), mean ± SD

Item	Preop study (n = 59)	Preop control (n = 61)	Preop P	Postop study (n = 59)	Postop control (n = 61)	Postop P
Functional domains
Physical function	82.3 ± 9.5	83.1 ± 8.9	0.615	88.6 ± 7.2	83.4 ± 8.6	< 0.001
Role function	79.6 ± 10.2	80.3 ± 9.8	0.694	86.2 ± 8.1	80.7 ± 9.3	< 0.001
Emotional function	75.8 ± 11.3	76.4 ± 10.7	0.763	83.5 ± 8.6	78.2 ± 9.8	0.002
Cognitive function	81.2 ± 9.8	82.0 ± 9.3	0.640	86.7 ± 7.5	83.9 ± 8.9	0.063
Social function	77.4 ± 10.6	78.2 ± 10.1	0.667	84.8 ± 8.3	79.1 ± 9.6	< 0.001
Global health status/QoL	65.3 ± 12.4	66.1 ± 11.8	0.712	78.9 ± 9.2	70.5 ± 10.8	< 0.001
Symptom domains
Fatigue	28.6 ± 8.9	29.3 ± 8.5	0.652	18.3 ± 6.4	24.7 ± 7.8	< 0.001
Pain	22.4 ± 7.6	23.1 ± 7.2	0.606	12.5 ± 5.3	18.9 ± 6.7	< 0.001
Nausea and vomiting	15.2 ± 5.8	15.8 ± 5.6	0.561	8.6 ± 4.2	13.4 ± 5.6	< 0.001
Single items
Dyspnea	18.3 ± 6.5	18.9 ± 6.2	0.601	15.7 ± 5.8	17.2 ± 6.4	0.171
Insomnia	24.6 ± 8.2	25.3 ± 7.9	0.629	20.4 ± 7.1	22.8 ± 7.6	0.070
Appetite loss	20.8 ± 7.3	21.5 ± 7.0	0.589	14.2 ± 5.6	16.3 ± 6.2	0.052
Constipation	19.5 ± 6.8	20.1 ± 6.5	0.612	16.8 ± 5.9	19.7 ± 6.3	0.011
Diarrhea	16.7 ± 5.9	17.3 ± 5.7	0.570	13.5 ± 5.2	16.3 ± 5.8	0.007
Financial difficulties	22.3 ± 7.8	23.0 ± 7.5	0.612	19.6 ± 6.9	21.2 ± 7.3	0.206

QoL: Quality of life.